Pharma Journalist -

Boston Biomedical announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for DSP-7888, an investigational cancer peptide vaccine, for the…
Read More...

AbbVie announced a research, option and license agreement whereby AbbVie obtained an exclusive option to license up to three of Turnstone's next-generation oncolytic viral…
Read More...

Astellas Pharma and Seattle Genetics announced dosing of the first patient in EV-201, a registrational phase 2 clinical trial of enfortumab vedotin for patients with locally advanced or…
Read More...

Allergan announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ulipristal acetate, an investigational drug for the treatment…
Read More...

Ansun BioPharma announced that the Division of Antiviral Products of the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Ansun's first-in-class…
Read More...

Boehringer Ingelheim announced that the supplemental New Drug Application (sNDA) for Gilotrif® (afatinib) has been accepted for filing and granted Priority Review by the U.S. Food and…
Read More...

AstraZeneca, along with MedImmune, its global biologics research and development arm, has announced that the European Medicines Agency (EMA) has accepted a Marketing…
Read More...

Pharmacy technology provider Parata Systems has entered a group purchasing agreement with American Associated Pharmacies, a member-owned cooperative representing more than 2,200…
Read More...

Piramal Pharma Solutions (PPS) announced investments of $55 million across its sites in North America & Asia, to expand its API manufacturing capabilities and capacities. A part…
Read More...

Merck announced its strategic decision to discontinue the development of the investigational combination regimens MK-3682B (grazoprevir/ruzasvir/ uprifosbuvir) and MK-3682C…
Read More...